Home / Business and Economy / Jio IPO Soars, Paras Healthcare IPO Trails Behind
Jio IPO Soars, Paras Healthcare IPO Trails Behind
24 Oct
Summary
- Jio IPO subscribed over five times; QIBs led demand.
- Paras Healthcare IPO saw subdued interest, subscribed 0.34 times.
- Jio IPO GMP at ₹240, predicting a 21.45% listing gain.
The subscription period for the Reliance Jio Platforms and Paras Healthcare IPOs closed on Friday, October 23, 2026. Both mainboard IPOs opened for bidding on Wednesday, October 21, 2026.
Reliance Jio Platforms' ₹30,213-crore IPO garnered substantial investor interest, with overall subscriptions exceeding five times. Qualified Institutional Buyers showed strong demand, subscribing their portion 13.29 times, while retail investors subscribed 1.35 times and non-institutional investors 5.97 times.
Conversely, Paras Healthcare's ₹1,450-crore IPO faced a subdued response. By the close of bidding on October 22, 2026, the issue was subscribed only 0.34 times. Retail investors participated more actively, with their portion subscribed 1.31 times, but the NII segment remained weak at 0.25 times.
Grey market premium (GMP) trends reveal a significant divergence in investor sentiment. Reliance Jio Platforms commanded a notable GMP of ₹240 per share, implying a potential listing gain of around 21.45% over its upper price band of ₹1,119. Paras Healthcare's GMP was considerably lower at ₹13, forecasting a more modest listing gain of approximately 1.88% over its upper price band of ₹693, with an estimated listing price of ₹706.
